Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02045446 · ClinicalTrials.gov registry record · Phase 2
Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial
A Phase 2 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 29
- Enrollment target
NCT02045446 is a Phase 2 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 29 participants.
The verdict
NCT02045446, a Phase 2 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 29 participants
- Enrollment target
Study Summary
The core hypothesis to be tested is that the use of consolidative SBRT followed by maintenance chemotherapy in patients with less than or equal to 6 metastatic sites (primary + 5) will improve progression free survival (PFS) compared to maintenance chemotherapy alone.
Interventions
- RADIATION Stereotactic Body Radiation Therapy
- DRUG Maintenance chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2014-02 |
| Est. Completion | 2022-05-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02045446
The ClinicalTrials.gov registry entry for NCT02045446 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stereotactic Body Radiation Therapy is the first listed.
NCT02045446 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02045446 about?
NCT02045446 is a clinical study titled "Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial". The core hypothesis to be tested is that the use of consolidative SBRT followed by maintenance chemotherapy in patients with less than or equal to 6 metastatic sites (primary + 5) will improve progression free survival (PFS) compared to maintenance chemotherapy alone.
What is the current status of trial NCT02045446?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 29 participants. The study started on 2014-02. Estimated completion is 2022-05-02.
What interventions are being tested in trial NCT02045446?
The interventions under investigation include: Stereotactic Body Radiation Therapy (RADIATION), Maintenance chemotherapy (DRUG).
Who is sponsoring clinical trial NCT02045446?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.